DIRS.INFO The most relevant business & tech news

☆ Nearly half of online pharmacies selling weight loss drugs are operating illegally, study finds
▼ + stars: | 2024-08-02 | by ( Liz Szabo | Liz Szabo Is An Independent Health | Science Journalist. Her Work Has Won Multiple National Awards. One Of Her Investigations Led To A New State Law In Virginia. | ) www.nbcnews.com time to read: +8 min

Consumers who try to buy popular weight loss drugs online without a prescription risk being scammed or receiving unsafe products, a new study shows. Shortages of the popular weight loss medication, which belongs to a class of drugs called GLP-1s, have led to “a black market of illegal knockoffs,” said Dr. Christopher McGowan, the founder, medical director and research director of True You Weight Loss, a weight loss clinic in Cary, North Carolina. Medicare doesn’t cover the drugs when prescribed for weight loss, and many state Medicaid plans heavily restrict coverage. Online scamsSome websites purporting to be online pharmacies take consumers’ money but never deliver the medications, according to the study. Consumers won’t get that sort of care if they buy drugs online without seeing a health care provider.

Persons: ”, Tim Mackey, Christopher McGowan, McGowan, semaglutide, won’t, Mackey, ” McGowan, “, Shabbir Safdar, Scott Brunner, Safdar, Brunner, Consumers won’t, it’s Organizations: Nordisk’s, University of California, Global Health, Data Institute, University of Pecs, FDA, Manufacturers can’t, Medicare, JAMA, Food and Drug Administration, semaglutide, Novo Nordisk, telltale, Partnership, Safe Medicines, Alliance, Pharmacy, Consumers Locations: San Diego, Hungary, Cary , North Carolina, U.S

☆ Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
▼ + stars: | 2024-08-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. All doses of Eli Lilly's highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug Administration's drug shortage database on Friday. The FDA's update comes one day after Eli Lilly CEO David Ricks told Bloomberg that the shortages of Mounjaro and Zepbound would end "very soon." A spokesperson for Eli Lilly did not immediately respond to CNBC's request for comment on the FDA's update on Friday. Meanwhile, the FDA said some doses of Novo Nordisk's weight loss drug Wegovy have limited supply.

Persons: Eli Lilly’s, Eli Lilly's, Zepbound, Eli Lilly, David Ricks Organizations: U.S . Food, Novo Nordisk, Bloomberg, FDA Locations: New York City, U.S

☆ Forget Ozempic — an under-the-radar antiaging supplement is the next hot commodity in Hollywood
▼ + stars: | 2024-08-02 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +9 min

She was talking about NAD+ boosters — the antiaging elixirs that have joined the ranks of Ozempic and Botox as staples of elite wellness routines. Even the military is testing out NAD boosters, hoping they might someday rejuvenate soldiers on the battlefield. "NAD coenzymes are the central catalysts of all living things," Charles Brenner, a biochemist who studies NAD, told Business Insider. AdvertisementTo boost NAD, don't take NADThere is a plethora of various powders, pills, and IV drips all promising to boost NAD. How to boost your NAD without an IV dripChicken, fish, and edamame all help boost our NAD levels.

Persons: —, I'm, Hailey Bieber, Joe Rogan, Stephane Cardinale, Charles Brenner, Robert Fried, Brenner, Fried, Dr, Sabine Donnai, She's, Shin, ichiro Imai, Louis who's, nicotinamide, Jeffrey Coolidge, pricey, Donnai, We're, Kourtney Kardashian, Arturo Holmes, Shalender Bhasin, hasn't Organizations: Service, Ozempic, Business, Hollywood, US Food and Drug Administration, Images Nutrition, Washington University School of Medicine, NAM, Brigham, Women's Hospital Locations: London, St, Boston

☆ Organic and regular dark chocolate contaminated by lead and cadmium, study finds
▼ + stars: | 2024-07-31 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +7 min

As natural elements in the Earth’s crust, lead, cadmium and other heavy metals are in the soil in which crops are grown and thus can’t be avoided. The research team examined only pure dark chocolate products as they contain the highest amount of cacao, the raw, unprocessed part of the cacao bean. Gabi Musat/500px/Getty Images/FileLead and cadmium found, but no arsenicThe new study analyzed 72 consumer cocoa products for levels of lead, cadmium and arsenic. He authored a July study which analyzed 155 samples of chocolate and found higher levels of cadmium but little lead in dark chocolates. However, for healthy adults, Godebo’s risk analysis found little to worry about choosing to indulge in 1 ounce of dark chocolate now and again.

Persons: can’t, ”, Jane Houlihan, Houlihan, Gabi Musat, ’ ”, Danielle Fugere, ” Fugere, “, Leigh Frame, Tewodros Godebo, Godebo Organizations: CNN, Nutrition, Food and Drug Administration, National Confectioners Association, Consumer Labs, FDA, Integrative Medicine, Health, George Washington University, Tulane University School of Public Health, Tropical Medicine, Environmental Protection Agency, World Health Organization, “, WHO Locations: Washington ,, New Orleans

☆ GEHC gives reasons to look beyond temporary China woes and shares reverse higher
▼ + stars: | 2024-07-31 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. Organic revenue growth was 1%. We saw a continued acceleration of Vizamyl doses delivered in the U.S. in the second quarter. This is still a small contributor to sales growth but gives us optimism about its sales potential over the next few years." As a result, we're lowering our total company full-year organic revenue growth guidance."

Persons: Philips, It's, Eli Lilly, GEHC, —, Jay Saccaro, We're, Arduini, Peter Arduini, Jim Cramer's, Jim Cramer, Jim, Pavlo Gonchar Organizations: GE Healthcare, Management, Revenue, LSEG, General Electric, Philips, Siemens, Club, GE Healthcare YTD, GE Healthcare's, Care Solutions, Pharmaceutical Diagnostics, U.S, CNBC, Lightrocket, Getty Locations: China, Eisai, U.S

☆ Jim Cramer: Merck is a buy after the drugmaker's post-earnings dip — here's why
▼ + stars: | 2024-07-30 | by ( Matthew J. Belvedere | ) www.cnbc.com time to read: +1 min

Merck : The drugmaker reported a better-than-expected quarter. It raised its full-year sales outlook but was still a little short of estimates. Jim Cramer said Tuesday he would take advantage of the dip and buy Merck ahead of the benefit from this drug. Pfizer : Better-than-expected sales and adjusted earnings, as well as a full-year outlook raise, were not enough to keep the stock higher. PayPal : The digital payments company reported a better-than-expected quarter.

Persons: Jim Cramer's, Jim Cramer, Cramer, Alex Chriss, Anthony Noto Organizations: CNBC, Club, Merck, FDA, Pfizer, PayPal, Aerospace

☆ Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
▼ + stars: | 2024-07-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The newly FDA approved Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023. The breakthrough Alzheimer's drug Leqembi slowed disease progression in patients over three years, demonstrating the need for them to stay on the treatment long term, according to new data released Tuesday by Japanese drugmaker Eisai. The study results on Leqembi, which Eisai shares with Biogen , also found that a patient's Alzheimer's disease worsens after they stop treatment. The results are a first glimpse at what Alzheimer's patients' future could look like on therapies such as Leqembi, which is currently taken twice a month through an infusion. By 2050, the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S.

Persons: Lynn Kramer, Leqembi, Eisai, Kramer Organizations: FDA, Abington Neurological Associates, Biogen, CNBC, Alzheimer's Association International Conference, Alzheimer's Association Locations: Abington, Abington , PA, U.S, Philadelphia

☆ Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial
▼ + stars: | 2024-07-30 | by ( Meg Tirrell | ) edition.cnn.com time to read: +7 min

“This is the first study that actually looked at a relatively large number of patients for whether there is any neuroprotective effect in Alzheimer’s disease,” Edison said. The trial enrolled predominantly people with mild Alzheimer’s disease, measured by a test known as the Mini-Mental State Examination, a scale that goes up to 30. The GLP-1 drug class also includes Eli Lilly’s Mounjaro and Zepbound, which use the active ingredient tirzepatide, which mimics not just the hormone GLP-1 but another called GIP. But it hasn’t announced any trials of its GLP-1 drugs in Alzheimer’s. GLP-1 drugs can have side effects, though, primarily gastrointestinal problems like nausea and vomiting.

Persons: liraglutide, “, ”, Maria Carrillo, Carrillo, Paul Edison, ” Edison, Edison, Eli Lilly’s Mounjaro, Alzheimer’s Lilly, hasn’t, Lilly, Lars Fruergaard Jorgensen, there’s, Dr, Sanjay Gupta, semaglutide Organizations: CNN, Alzheimer’s Association International Conference, Alzheimer’s Association, Novo Nordisk, Imperial College London, ”, Nordisk, ” Novo Nordisk, CNN Health, University of Oxford, Alzheimer’s Society, Alzheimer’s Locations: United Kingdom, Philadelphia, Alzheimer’s, ” Novo, Danish

☆ A new blood test can spot signs of colon cancer in your annual blood draw
▼ + stars: | 2024-07-30 | by ( ) www.businessinsider.com time to read: +3 min

The organization also estimates more than 150,000 new cases of colorectal cancer will be diagnosed this year. Colon cancer is highly treatable when caught before it spreads to other areas of the body, according to the National Cancer Institute. However, the rate of diagnoses and deaths from colon cancer has been steadily going up in people under 45, alarming doctors and researchers. AdvertisementWe don't fully understand why younger people are getting colon cancer and dying from it more frequently. Risk factors for colorectal cancer include genetics, a family history of colon cancer or colorectal polyps, and other health conditions such as inflammatory bowel disease.

Persons: —, it's, David Chung, Guardant, Chung, Colon Organizations: Service, Drug Administration, Guardant Health, Business, Harvard Medical, FDA, American Cancer Society, National Cancer Institute Locations: Colon

☆ Big Tobacco’s viral hit may be its biggest success since cigarettes
▼ + stars: | 2024-07-27 | by ( Nathaniel Meyersohn | ) edition.cnn.com time to read: +7 min

While it’s ultimately owned by tobacco giant Philip Morris International, Zyn is a tobacco-free product. Unlike traditional chewing tobacco, you don’t have to chew the pouches or spit the build-up of tobacco juice. ‘Zynfluencers’Zyn users like Danny Whalen, 26, switched to nicotine pouches last year after 10 years of chewing tobacco. (Philip Morris International told CNN it only advertises at events with an adult audience of over 85%.) Philip Morris International, which split from Phillip Morris USA, does not sell cigarettes in the United States.

Persons: Philip Morris, Bing Guan, Zyn, Phillip Morris, ” — Phillip Morris, Danny Whalen, Whalen, doesn’t, ” Whalen, “, —, Tucker Carlson, Joe Rogan, Logan Paul, “ ZYN, “ Zyn, ”, Pamela Ling, ” Phillip Morris, Ling, ” Ling Organizations: New, New York CNN, it’s, Philip Morris International, Bloomberg, Getty, Phillip Morris International, ” — Phillip Morris International, Rutgers Institute, Tobacco Studies, Rutgers, Boys, Spotify, CNN, Facebook, ESPN, Beale, Music, Pickleball, Center for Tobacco Control Research, Education, University of California San, ” Phillip Morris International, National Cancer Institute, Phillip Morris USA Locations: New York, United States, Aurora , Colorado, TikTok, University of California San Francisco

☆ The FDA is now investigating if Diamond Shruumz 'microdosing' products are linked to multiple deaths
▼ + stars: | 2024-07-27 | by ( Lauren Edmonds | ) www.businessinsider.com time to read: +1 min

The FDA reported 74 illnesses in 28 states possibly linked to Diamond Shruumz products. Now the agency says it is investigating two deaths it suspects are associated with the products. Diamond Shruumz has recalled all its microdosing chocolate bars, infused cones, and gummies. AdvertisementThe Food and Drug Administration is investigating if products sold by Diamond Shruumz, the company that recalled its microdosing products in June, are now linked to two deaths. The FDA shared the update with the public this week amid its investigation into illnesses the agency suspects are associated with Diamond Shruumz products.

Persons: Shruumz, —, Diamond Shruumz Organizations: FDA, Service, Drug Administration, Diamond, Business

☆ The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear
▼ + stars: | 2024-07-27 | by ( Lauren Edmonds | ) www.businessinsider.com time to read: +1 min

The FDA said people may be overdosing on knock-off semaglutide weight-loss drugs. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . You can opt-out at any time by visiting our Preferences page or by clicking "unsubscribe" at the bottom of the email. AdvertisementThe US Food and Drug Administration says some people have been hospitalized with symptoms that may be related to overdoses from injectable weight-loss drugs. This story is available exclusively to Business Insider subscribers.

Persons: — Organizations: FDA, Service, Food and Drug Administration, Business

☆ Should I use a smartwatch to track my health data? A doctor explains
▼ + stars: | 2024-07-26 | by ( Katia Hetter | ) edition.cnn.com time to read: +9 min

To sort out my smartwatch health and fitness questions, I spoke with CNN wellness expert Dr. Leana Wen. A smartwatch with a heart rate monitor can help athletes track their heart rates to keep them in a certain range. Wen: What a lot of active people do is to track heart rate during exercise to keep the heart rate in a certain range. This is where the heart rate is under 70% to 75% of your maximal heart rate. Many smartwatches track sleep and can tell you how long you’ve slept and how much time you spent in each sleep stage.

Persons: CNN —, Leana Wen, Wen, I’ve, aren’t, it’s Organizations: CNN, Intelligence, George Washington University, Bluetooth, Apple Watch, Samsung Galaxy, US Food and Drug Administration, FDA Locations: what’s

☆ Bristol Myers surges 10%, its biggest increase since 2008, after boosting profit forecast
▼ + stars: | 2024-07-26 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +3 min

Bristol Myers boosted its adjusted earnings for the year to between 60 and 90 cents a share, up 20 cents from its last forecast. AdvertisementOf Bristol Myers' existing drugs, Eliquis saw a 7% increase in sales year-over-year. Cancer drug Opdivo and blood cancer treatment Revlimid also saw promising results and beat quarterly sales estimates. The company reiterated its plan to cut $1.5 billion in costs by 2025, which was announced at its last quarterly earnings call. Bristol Myers is only the latest of a host of other drugmakers to raise their earnings guidance this week.

Persons: Myers, —, Bristol Myers, Christopher Boerner, Eliquis, Revlimid, David Elkins, Boerner, AbbVie Organizations: Bristol, Myers Squibb, Service, Cancer, FDA, AstraZeneca, Roche, Sanofi Locations: Bristol

☆ Viking Therapeutics stock jumps 30% after drugmaker moves weight loss injection to late-stage trial
▼ + stars: | 2024-07-25 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Shares of Viking Therapeutics jumped more than 30% on Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected. Viking is one of several small and large drugmakers hoping to compete in the space against Novo Nordisk and Eli Lilly , whose weight loss and diabetes GLP-1s have skyrocketed in demand over the last two years. During the call, Lian added that Viking expects to test VK2735 as a monthly injection in a future study. Viking Therapeutics' drug promotes weight loss by targeting a GLP-1 and another hormone called GIP. That pill caused 3.3% weight loss when compared to a placebo in an early-stage trial.

Persons: Eli Lilly, Viking, Brian Lian, Lian, Justin Zelin, Zelin, Eli Lilly's Zepbound Organizations: Viking Therapeutics, San, Novo Nordisk, Food and Drug Administration, FDA, Novo Nordisk's Wegovy Locations: San Diego

☆ Forget keto — Ozempic might finally kill the low-carb diet trend
▼ + stars: | 2024-07-23 | by ( ) www.businessinsider.com time to read: +5 min

Read previewHold the butter — the rise of weight loss medications may be signaling an end to popular high-fat, low-carb diet trends. But interest has begun to wane in recent years, with the number of people on keto diets dropping by 4% in 2023. Some doctors have called keto the worst diet for healthDespite hitting its stride in the mid-2010s, the keto diet has been around for at least a century. Both saturated fat and processed meats are popular in low-carb diet variations like "dirty keto," full of junk food. GLP-1 drugs work for weight loss by mimicking various hormones that naturally occur in the human body and help regulate appetite.

Persons: —, Ozempic, Atkins, they're Organizations: Service, Google, New, Business, Consumer, FDA Locations: carbs, dietitian

☆ We're raising our price target on Danaher stock as it sheds a major overhang
▼ + stars: | 2024-07-23 | by ( Zev Fima | ) www.cnbc.com time to read: +10 min

That improvement in the bioprocessing end market is super important because it has been a huge overhang for Danaher shares, and the life sciences space in general. We were concerned about the bioprocessing market after rival Sartorius cut its guidance last week. The management team has effectively navigated the bioprocessing slowdown better than others and kept expectations managed — a big reason we've stuck by the stock during a difficult few quarters. Based on these strong results and the improving bioprocessing market, we are raising our price target to $295 from $280 and reiterating our 1 rating. All three operating segments are expected to post sales decline rates in the low single digits.

Persons: Sartorius, Rainer Blair, Danaher, Blair, Beckman Coulter, Jim Cramer's, Jim Cramer, Jim, Igor Golovnov Organizations: Club, Revenue, LSEG, Management, Diagnostics, Leica, Beckman Coulter Diagnostics, Cepheid, CNBC, Getty Locations: bioprocessing, Danaher, U.S, Europe, China, Bioprocessing

☆ From Zyn to vapes: Big Tobacco pushes further toward cigarette alternatives. Here’s who could come out on top
▼ + stars: | 2024-07-21 | by ( Michelle Fox | ) www.cnbc.com time to read: +12 min

If you haven't been paying attention to tobacco companies, you might not recognize the new landscape. The alternatives also include heated tobacco and nicotine vapor products, although with the latter, tobacco companies face big competition from vaping companies and the proliferation of illicit vapes. PM 1Y mountain Philip Morris' one-year performance Countries around the globe have been working for years to reduce tobacco use. There is no way back," Philip Morris Chief Financial Officer Emmanuel Babeau said at a Deutsche Bank conference in June. Most of that came from companies in China, with tobacco companies only taking about 15% share, the bank said.

Persons: Philip Morris, —, Brett Cooper, I'm, Philip, Emmanuel Babeau, Owen Bennett, Cooper, Altria, vapes —, Faham Baig, Dan Ahrens, Ahrens, Edge's Cooper, Jefferies, Bennett, Murray Garnick Organizations: Philip Morris International, Reynolds American, British, Tobacco, Big Tobacco, World Health, Philip Morris, Deutsche Bank, Jefferies, Philip Morris USA, Centers for Disease Control, Drug Administration, U.S, Supreme, FDA, UBS, WHO, Brands, BAT Locations: Colorado, China, rey, Japan, Iquos, U.S, Kentucky, Marlboro, U.S ., London, RRPs

☆ Dozens of illnesses across 28 states are now linked to a company's 'microdosing' gummies and chocolate bars
▼ + stars: | 2024-07-21 | by ( Lauren Edmonds | ) www.businessinsider.com time to read: +1 min

Over five dozen people reported seeking medical attention after consuming Diamond Shruumz products. The FDA reported 36 hospitalizations and one potential death associated with the products. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementDiamond Shruumz, the company whose microdosing chocolate bars prompted an FDA investigation in June, has also sold gummies made with an illegal substance, according to a new CDC report. The FDA first alerted the general public about Diamond Shruumz products after eight people in four states fell ill from consuming the retailer's microdosing chocolate bars.

Persons: —, gummies Organizations: FDA, Service, CDC, Diamond, Business

☆ Sealed bottles of tattoo and permanent makeup ink test positive for millions of bacteria, FDA says
▼ + stars: | 2024-07-18 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +8 min

CNN —Sealed bottles of tattoo and permanent makeup ink, including some marked as sterile, contained millions of potentially dangerous bacteria, according to new research by the US Food and Drug Administration. Earlier studies have found high levels of bacterial contamination within sealed and sterile bottles of ink. Unfortunately, the study’s findings were not surprising, said John Swierk, an assistant professor of chemistry at Binghamton University, State University of New York, who has studied tattoo ink contamination. For example, using the same gloves to touch a client and the ink bottle is a hazard that can lead to tattoo ink contamination. “Tattoo inks are in the process of being regulated due to the Modernization of Cosmetics Regulation Act (of 2022) but much of that law dealing with tattoo inks has yet to be implemented,” Swierk said.

Persons: ”, Peter, Kim, Linda Katz, ” Katz, Katz, John Swierk, Swierk, Selina Medina, ” Medina, Robert Schooley, “, ’ ”, Schooley, Medina, miodrag ignjatovic, ” Swierk Organizations: CNN, US Food and Drug Administration, National, for Toxicological Research, Cosmetics, US Centers for Disease Control, Binghamton University, State University of New, Alliance, Professional, Manufacturers, FDA, CFU, University of California, Center, Therapeutics, Artists Locations: Jefferson , Arkansas, State University of New York, United States, San Diego, Medina

☆ The AI doctor will see you now: ChatGPT dominates medical exam
▼ + stars: | 2024-07-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe AI doctor will see you now: ChatGPT dominates medical examFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss which AI large language models (LLM) scored the highest in the same medical exam doctors have to answer to get a medical license, future of AI-powered healthcare,

Persons: Scott Gottlieb

☆ Shares of this controversial health-care stock poised to break out to new high, according to the charts
▼ + stars: | 2024-07-16 | by ( Todd Gordon | ) www.cnbc.com time to read: +3 min

Shares of Hims & Hers (HIMS) , a digital consumer-facing health-care company, look poised to break out to a new all time high, according to the charts. HIMS announced in May a controversial weight loss injection product to compete with Lilly's Ozempic and Novo Nordisk's Wegovy. HIMS is not only marketing weight loss drugs, it has over one million subscribers using a wide variety of treatments. It's no secret that the total addressable market for weight loss drugs is gigantic. he volume was massive that day at over 70 million shares traded with average daily volume at round 18 million.

Persons: Howard Marks, HIMS, Lilly's, We've, Goldman Sachs, Eli Lilly's, Todd Gordon, Gordon Organizations: Capital Management, Novo Nordisk's Wegovy, Edge, Inside Edge, CNBC, NBC UNIVERSAL

☆ I tried both Botox and face tape for my forehead lines. Neither is perfect, but one feels better in the long run.
▼ + stars: | 2024-07-11 | by ( Julia Pugachevsky | ) www.businessinsider.com time to read: +5 min

Within less than a week, my forehead was completely smooth, and I got more compliments on how amazing my skin looked. My forehead would stay smooth shortly after I'd remove them, but revert back a little later in the day. I also had to be consistent: it took about a week of wearing them every night for my forehead to smooth out. Face-taping gives me more of a natural lookWhile Botox had stronger effects than face-taping, I didn't necessarily love it. I never had anything against forehead lines or visible signs of aging.

Persons: —, it's, Botox, I'm Organizations: Service, Business, FDA

☆ Tampons contain lead, arsenic and potentially toxic chemicals, studies say. Here’s what to know
▼ + stars: | 2024-07-11 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +9 min

CNN —The average menstruating person will spend about five years of their total reproductive lifespan using an estimated 11,000 tampons, sanitary pads, panty liners and other menstrual products, experts say. What if some of those menstrual aids contain heavy metals or potentially toxic chemicals linked to chronic diseases and reproductive and developmental problems? “I do not want people to panic, but to be aware that heavy metals have been found in these menstrual products,” Schilling said. “However, there is no reason for people to be afraid to use menstrual products at this time,” she added. The team ran tests for 16 heavy metals: arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, manganese, mercury, nickel, lead, selenium, strontium, vanadium and zinc.

Persons: Kathrin Schilling, ” Schilling, Amanda Hils, ” Hils, Anna Pollack, ”, Pollack, “, tampons Schilling, nonorganic tampons, hasn’t, Nancy King Reame, Reame Organizations: CNN, US Environmental Protection Agency, Columbia University’s Mailman, of Public Health, US Food and Drug Administration, George Mason University, US Geological Survey . Chemicals, Environmental Health, Institute for Green Science, Carnegie Mellon University, American Chemistry Council, “, for Disease Control, Prevention, FDA, School of Nursing, Columbia University Medical Center Locations: New York City, “, Fairfax , Virginia, United States, United Kingdom, Greece, tampons, Pittsburgh

☆ Musk says next Neuralink brain implant expected soon, despite issues with the first patient
▼ + stars: | 2024-07-10 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +3 min

Elon Musk said Wednesday that his brain tech startup Neuralink hopes to implant its system in a second human patient within "the next week or so." No BCI company has received approval from the U.S. Food and Drug Administration to commercialize their devices. In a livestream with Neuralink executives Wednesday, Musk said the company is hoping to implant its device in the "high single digits" of patients this year. However, in the weeks following the procedure, Neuralink said some threads from the implant retracted from Arbaugh's brain. Musk and the Neuralink executives said during Wednesday's livestream that only around 15% of the channels in Arbaugh's implant are functional.

Persons: Elon Musk, Musk, Neuralink, Noland Arbaugh, Wednesday's, DJ Seo, Matthew MacDougall Organizations: BCI, Neuroscience, U.S . Food, Drug Administration, Barrow Neurological, FDA, Wall Street, CNBC Locations: U.S, Barrow, Phoenix , Arizona, Neuralink

Search resuls for: "FDA"

25 mentions found